Founder & COOJon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Prime Medicine (NASDAQ:PRME) reported full-year 2025 financial results on Tuesday, signaling a strategic shift toward commercial-stage readiness as its "search-and-replace" gene editing platform achieves its first human clinical validations.
SOPHiA GENETICS (NASDAQ:SOPH) reported a strong finish to its fiscal year on Tuesday, pairing double-digit revenue growth with significant margin expansion as the healthcare-tech firm moves closer to its goal of operational profitability.
Kontoor Brands (NYSE:KTB) posted a sharp increase in fourth-quarter revenue on Tuesday, clearing the $1 billion threshold as the company reaps the benefits of its 2025 acquisition of Helly Hansen and continued momentum in its core denim business.
Esperion Therapeutics (NASDAQ:ESPR) moved to significantly broaden its cardiovascular portfolio on Tuesday, announcing a deal to acquire privately held Corstasis Therapeutics and its first-of-its-kind nasal spray for heart failure-related edema.
Amazon Web Services (AWS) disclosed on Tuesday that drone strikes directly hit two of its facilities in the United Arab Emirates.
Fold has retired $66.3 million in convertible debt, removing a potential source of shareholder dilution and simplifying its capital structure as it expands its Bitcoin rewards business.
Iranians have rushed to withdraw digital assets from local exchanges after coordinated US and Israeli strikes intensified conflict and rattled the country’s financial system.
The Hong Kong Monetary Authority and Shanghai authorities have agreed to study a blockchain-based cross-border platform linking cargo trade data, electronic bills of lading and financial applications under Project Ensemble.
Escalating conflict involving Iran is unlikely to significantly disrupt the global Bitcoin mining network, analysts and industry operators said, dismissing social media claims of a looming hashrate collapse and forced BTC sell-offs.
Precision BioSciences (NASDAQ:DTIL) announced Monday that it has achieved a $7.5 million clinical milestone under its licensing agreement with TG Therapeutics (NASDAQ:TGTX).
